Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9626 posts found.

Gilead’s pill shows promise in HIV prevention

November 25, 2010 Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
News

UN says Treatment 2.0 approach needed for AIDS

November 25, 2010 Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS

A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …
News

Brain cancer vaccine to move into phase III

November 24, 2010 Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma

Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …
News

Healthcare, politics and the NHS

November 24, 2010 Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine

I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …
Feature
Age-related macular degeneration (Wet AMD)

Bayer’s challenger to Lucentis shows promise

November 22, 2010 Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
News

Pfizer’s axitinib impresses in head-to-head trial with Nexavar

November 22, 2010 Research and Development, Sales and Marketing Kidney cancer, Nexavar, Pfizer, axitinib, mRCC, metastatic renal cell carcinoma

Pfizer’s axitinib has impressed in phase III trials assessing its efficacy as a second line treatment for renal cell carcinoma. …
News

Bayer set for 4,500 job cuts

November 19, 2010 Research and Development, Sales and Marketing Bayer, Cost cutting, emerging markets

Bayer has announced large scale job losses aimed at saving 800 million euro savings in the coming years.The cuts are …
News

BTG to buy Biocompatibles

November 19, 2010 Research and Development BTG, Biocompatibles

BTG is to pay £156 million to acquire Biocompatibles, the drug-device specialists.Established in 1984 and floated in 1995, Biocompatibles specialises …
News

Novartis outlines business strategy

November 18, 2010 Research and Development, Sales and Marketing Novartis, business development, pharma strategy

Novartis has outlined its long-term strategy for managing a number of key patent expiries. The Swiss-based pharma firm plans to …
News
Genzyme

Genzyme courting ‘white knight’ bid from Takeda

November 18, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers

Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
News
Roche job cuts

Roche set to cut 4,800 jobs worldwide

November 17, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Roche, avastin, cuts, taspoglutide

Roche’s ‘Operational Excellence’ programme will see it cut 6% of its global workforce over the next two years. The initiative …
News

Pfizer establishes new US research network

November 17, 2010 Research and Development, Sales and Marketing BiodiscoveryTherapeutics, MedImmune, Pfizer

Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …
News

Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs

November 17, 2010 Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer

A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …
News

First patient treated in groundbreaking stem cell trial

November 16, 2010 Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke

The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …
News

PolyTherics appoints Dr John Burt chief business officer

November 16, 2010 Manufacturing and Production, Research and Development Dr John Burt, PolyTherics, appointment, manufacturing and production, protein engineering, research and development

UK protein engineering company PolyTherics has appointed Dr John Burt as chief business officer. He was previously chief executive of …
Appointment
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026